Editors' ChoiceCancer

A two-step program preventing bone metastatic relapse

See allHide authors and affiliations

Science Translational Medicine  27 Nov 2019:
Vol. 11, Issue 520, eaaz9759
DOI: 10.1126/scitranslmed.aaz9759


Treating bone metastatic prostate cancer with docetaxel nanoparticles and denosumab averts tumor regrowth.

View Full Text

Stay Connected to Science Translational Medicine